Facebook Instagram X-twitter Linkedin

AOD 9064 (10mg)

Table of Contents

  • Quickstart Highlights

AOD 9064 (10mg) protocols focus on this modified fragment of human growth hormone designed to support lipolysis (fat breakdown) without the broader systemic effects of full GH activity. Research suggests it may help stimulate fat metabolism by targeting adipose tissue pathways involved in lipolysis and inhibiting lipogenesis. This guide outlines a subcutaneous administration approach optimized for the 10 mg vial format.

  • Reconstitute: Add 2.0 mL bacteriostatic water → 5 mg/mL concentration
  • Typical daily range: 250–500 mcg once or twice daily (subcutaneous)
  • Easy measuring: At 5 mg/mL, 1 unit = 0.01 mL = 50 mcg (0.05 mg) on a U-100 insulin syringe
  • Storage: Lyophilized: store at −20 °C; after reconstitution, refrigerate at 2–8 °C and use within 2–4 weeks
  • Protocol Overview

Concise summary of the subcutaneous regimen.

  • Goal: Support fat metabolism and lipolysis without systemic GH effects
  • Schedule: Daily subcutaneous injections, often split AM/PM
  • Dose Range: 250–500 mcg per day
  • Cycle Length: Commonly used in 4–12 week cycles, depending on protocol goals
  • Dosing Protocol

Suggested approach for the 10 mg vial format.

  • Start: 250 mcg once daily to assess tolerance
  • Target: 250–500 mcg once or twice daily
  • Frequency: 1–2 injections per day (subcutaneous)
  • Vial Duration: One 10 mg vial lasts approximately 20–40 days, depending on dose
  • Timing: Morning dosing preferred; second dose (if used) spaced in the afternoon or early evening
  • Mechanism of Action

AOD 9064 is a synthetic peptide derived from the C-terminal region of human growth hormone. Unlike full HGH, it is designed to selectively influence fat metabolism pathways without significantly affecting insulin-like growth factor 1 (IGF-1) levels.

It is believed to promote lipolysis (fat breakdown) and inhibit lipogenesis (fat storage) by acting directly on adipose tissue signaling pathways. Preclinical research suggests it may enhance fat oxidation while minimizing effects on blood sugar, growth pathways, or systemic hormone activity associated with full GH administration.

  • Potential Benefits & Side Effects

Observations based on preclinical and early research literature.

Potential Benefits:

  • May support reduction in body fat mass
  • May enhance fat oxidation and lipolysis
  • Minimal impact on IGF-1 compared to full HGH
  • Potential use in body composition improvement protocols

Possible Side Effects:

  • Mild injection-site irritation
  • Temporary water balance fluctuations reported in some users
  • Headache or fatigue in rare cases
  • Long-term human safety data is limited; remains investigational